Virological evolution in HIV treatment-experienced patients with raltegravir-based salvage regimens

被引：0
|
作者：
Katlama, C. [1 ]
Caby, F. [1 ]
Andrade, R. M. [1 ]
Schneider, L. [1 ]
Canestri, A. [1 ]
Ktroza, N. [1 ]
Tubiana, R. [1 ]
Valantin, M. A. [1 ]
Wirden, M. [2 ]
Mallet, I. [2 ]
Calvez, V. [2 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[2] Hop La Pitie Salpetriere, Dept Virol, Paris, France
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [1] Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
    José Antonio Mata-Marín
    Ariane Estrella Weiser Smeke
    Mariana Rotzinger Rodriguez
    Marcelino Chávez-García
    Marco Isaac Banda-Lara
    Alma Minerva Pérez Rios
    Nohemí Nuñez-Rodríguez
    Juan Carlos Domínguez-Hermosillo
    Alberto Chaparro Sánchez
    Irene Juarez-Kasusky
    Javier Enrique Cruz Herrera
    Jorge Luis Sandoval Ramírez
    Jesús Gaytán-Martínez
    Drugs in R&D, 2017, 17 : 225 - 231
  • [2] Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
    Antonio Mata-Marin, Jose
    Weiser Smeke, Ariane Estrella
    Rotzinger Rodriguez, Mariana
    Chavez-Garcia, Marcelino
    Isaac Banda-Lara, Marco
    Perez Rios, Alma Minerva
    Nunez-Rodriguez, Nohemi
    Carlos Dominguez-Hermosillo, Juan
    Chaparro Sanchez, Alberto
    Juarez-Kasusky, Irene
    Cruz Herrera, Javier Enrique
    Sandoval Ramirez, Jorge Luis
    Gaytan-Martinez, Jesus
    DRUGS IN R&D, 2017, 17 (01) : 225 - 231
  • [3] Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir With and Without Maraviroc Coadministration
    Baroncelli, Silvia
    Villani, Paola
    Weimer, Liliana E.
    Ladisa, Nicoletta
    Francisci, Daniela
    Tommasi, Chiara
    Vullo, Vincenzo
    Preziosi, Roberta
    Cicalini, Stefania
    Cusato, Maria
    Galluzzo, Clementina M.
    Floridia, Marco
    Regazzi, Mario
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 838 - 843
  • [4] Clinical, immunological, and virological outcomes in HIV patients on raltegravir-based salvage therapy
    Deshwal, Rajesh
    Arora, Sumit
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2019, 40 (01) : 42 - 45
  • [5] Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study
    Capetti, Amedeo
    Meraviglia, Paola
    Landonio, Simona
    Sterrantino, Gaetana
    Di Biagio, Antonio
    Lo Caputo, Sergio
    Ammassari, Adriana
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Franzetti, Marco
    Soria, Alessandro
    Meschiari, Marianna
    Sasset, Lolita
    Pellicano, Giovanni
    Mazzotta, Elena
    Trezzi, Michele
    Celesia, Benedetto Maurizio
    Melzi, Sara
    Carenzi, Laura
    Ricci, Elena
    Rizzardini, Giuliano
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (02) : 189 - 194
  • [6] Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir With and Without Maraviroc Coadministration (vol 44, pg 838, 2010)
    Baroncelli, Silvia
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (7-8) : 1352 - 1352
  • [7] Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors
    Bucciardini, R.
    D'Ettorre, G.
    Baroncelli, S.
    Ceccarelli, G.
    Parruti, G.
    Weimer, L. E.
    Fragola, V.
    Galluzzo, C. M.
    Pirillo, M. F.
    Lucattini, S.
    Bellagamba, R.
    Francisci, D.
    Ladisa, N.
    Antoni, A. Degli
    Guaraldi, G.
    Manconi, P. E.
    Vullo, V.
    Preziosi, R.
    Cirioni, O.
    Verucchi, G.
    Floridia, M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (07) : 459 - 463
  • [8] Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
    Bianco, Claudia
    Meini, Genny
    Rossetti, Barbara
    Lamonica, Silvia
    Mondi, Annalisa
    Belmonti, Simone
    Fanti, Luri
    Ciccarelli, Nicoletta
    Di Giambenedetto, Simona
    Zazzi, Maurizio
    De Luca, Andrea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 182 - 183
  • [9] Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients
    Caby, Fabienne
    Valin, Nadia
    Marcelin, Anne Genevieve
    Schneider, Luminata
    Andrade, Regis
    Guiguet, Marguerite
    Tubiana, Roland
    Canestri, Ana
    Valantin, Marc Antoine
    Peytavin, Gilles
    Pacanowski, Jerome
    Morand-Joubert, Laurence
    Calvez, Vincent
    Girard, Pierre Marie
    Katlama, Christine
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (6-7) : 527 - 532
  • [10] Patterns of Adherence to Raltegravir-Based Regimens and the Risk of Virological Failure Among HIV-Infected Patients: The RALTECAPS Cohort Study
    Gras, Guillaume
    Schneider, Marie-Paule
    Cavassini, Matthias
    Lucht, Frederic
    Loilier, Magalie
    Verdon, Renaud
    Bernard, Louis
    Parienti, Jean-Jacques
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) : 265 - 269
12345